Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with China Rongtong Academy of Sciences Group Co., Ltd.
0 Patents (Medical) associated with China Rongtong Academy of Sciences Group Co., Ltd.
100 Deals associated with China Rongtong Academy of Sciences Group Co., Ltd.
100 Translational Medicine associated with China Rongtong Academy of Sciences Group Co., Ltd.